Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93,761Revenue $M7,670Net Margin (%)30.4Altman Z-Score7.4
Enterprise Value $M93,259EPS $2.4Operating Margin %37.6Piotroski F-Score8
P/E(ttm)40.4Beneish M-Score-2.5Pre-tax Margin (%)35.2Higher ROA y-yY
Price/Book13.910-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales12.35-y EBITDA Growth Rate %23.1Current Ratio4.6Lower Leverage y-yN
Price/Free Cash Flow33.9y-y EBITDA Growth Rate %71.3ROA % (ttm)15.3Higher Current Ratio y-yY
Dividend Yield %--PEG1.7ROE % (ttm)43.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M793ROIC % (ttm)46.7Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGRonald Muhlenkamp 2015-03-31 Reduce-0.02%$110.51 - $128.5
($119.49)
$ 115.74-3%Reduce 0.81%85,540
CELGJoel Greenblatt 2015-03-31 Add0.01%$110.51 - $128.5
($119.49)
$ 115.74-3%Add 75.33%17,987
CELGMario Gabelli 2015-03-31 Reduce$110.51 - $128.5
($119.49)
$ 115.74-3%Reduce 0.08%24,940
CELGKen Fisher 2015-03-31 Add$110.51 - $128.5
($119.49)
$ 115.74-3%Add 1.14%229,918
CELGRonald Muhlenkamp 2014-12-31 Reduce-1.03%$86.38 - $118.68
($105.53)
$ 115.7410%Reduce 41.31%86,240
CELGJoel Greenblatt 2014-12-31 Buy 0.01%$86.38 - $118.68
($105.73)
$ 115.749%New holding10,259
CELGGeorge Soros 2014-09-30 Sold Out -0.45%$83.13 - $96.21
($90.29)
$ 115.7428%Sold Out0
CELGJoel Greenblatt 2014-09-30 Sold Out -0.07%$83.13 - $96.21
($90.29)
$ 115.7428%Sold Out0
CELGKen Fisher 2014-09-30 Add0.02%$83.13 - $96.21
($90.29)
$ 115.7428%Add 77.12%232,137
CELGRonald Muhlenkamp 2014-06-30 Reduce-1.91%$68.45 - $86.8
($75.89)
$ 115.7453%Reduce 51.74%144,140
CELGGeorge Soros 2014-06-30 Buy 0.45%$68.45 - $86.8
($75.89)
$ 115.7453%New holding688,000
CELGJoel Greenblatt 2014-06-30 Buy 0.07%$68.45 - $86.8
($75.89)
$ 115.7453%New holding63,980
CELGKen Fisher 2014-06-30 Add0.01%$68.45 - $86.8
($75.89)
$ 115.7453%Add 75.59%131,064
CELGRonald Muhlenkamp 2014-03-31 Add0.05%$69.645 - $85.97
($79.19)
$ 115.7446%Add 1.29%298,650
CELGKen Fisher 2014-03-31 Add0.01%$69.645 - $85.97
($79.19)
$ 115.7446%Add 1591.80%74,642
CELGMario Gabelli 2014-03-31 Reduce$69.645 - $85.97
($79.19)
$ 115.7446%Reduce 3.58%21,540
CELGJohn Keeley 2014-03-31 Sold Out $69.65 - $85.97
($79.19)
$ 115.7446%Sold Out0
CELGRonald Muhlenkamp 2013-12-31 Add0.12%$72.245 - $85.385
($79.13)
$ 115.7446%Add 2.87%294,850
CELGMario Gabelli 2013-12-31 Add$72.245 - $85.385
($79.13)
$ 115.7446%Add 6.69%22,340
CELGKen Fisher 2013-12-31 Reduce$72.245 - $85.385
($79.13)
$ 115.7446%Reduce 11.41%4,412
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KAPLAN GILLADirector 2015-06-10Sell15,000$111.745.8view
CASEY MICHAEL DDirector 2015-06-09Sell15,000$111.186.33view
STEIN LAWRENCE VSee Remarks 2015-05-14Sell2,542$114.852.93view
KAPLAN GILLADirector 2015-02-26Sell15,000$122.89-3.8view
CASEY MICHAEL DDirector 2015-02-25Sell15,000$123.19-4.03view
KARSEN PERRY Asee remarks 2015-02-11Sell27,896$120.12-1.58view
Alles Mark JSee Remarks 2015-02-06Sell117,099$120.68-2.04view
STEIN LAWRENCE VSee Remarks 2015-01-15Sell26,666$120.01-1.49view
KAPLAN GILLADirector 2015-01-02Sell45,536$113.474.19view
Daniel Thomas Osee remarks 2014-12-15Sell30,000$115.062.75view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
My Top 3 Pharma Stock Picks Jun 09 2015 
10 Reasons Why Growth Stocks Can Be Appropriate for Retired Investors Jun 04 2015 
Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
jee's porfolio May 23 2015 
Celgene’s Earnings Shine While Revenue Misses By An Inch In The First Quarter May 06 2015 
February Pick Of Biotech Stocks Feb 17 2015 
Celleration Acquisition Just the Start of Alliqua’s M&A Strategy Feb 04 2015 
J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated and Nov 18 2014 
Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Coun Nov 17 2014 

More From Other Websites
Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point Jul 01 2015
Celgene’s $138,000 Doctor Payment Left Out of Journal Disclosure Jul 01 2015
A cure for cancer? Jul 01 2015
Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress -... Jul 01 2015
Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, TransUnion Jul 01 2015
Celgene Shoots for Moon With Juno Jun 30 2015
Cramer: Despite Greece, signs of life Jun 30 2015
Juno-Celgene Deal Has Street Cautiously Optimistic Jun 30 2015
Celgene bet $1 billion that this biotech’s science can cure deadly cancers Jun 30 2015
Morgan Stanley Just Cut Juno Therapeutics' Price Target Jun 30 2015
Why is Celgene So Darn Expensive? Jun 30 2015
Juno shares skyrocket Jun 30 2015
Stocks Higher Tuesday after Monday's Selloff Jun 30 2015
Analysts Diverge On Celgene's Deal With Juno Therapeutics Jun 30 2015
Exxon tries to break losing streak; Juno & Celgene drug deal; Apollo flunks Jun 30 2015
Did Celgene Make the Right Move with its Juno Deal? What the Wags Say… Jun 30 2015
Is Celgene's Juno Deal a Boon or a Boondoggle? Jun 30 2015
Celgene (CELG) Stock Gains on 10-Year $1 Billion Drug Development Deal With Juno Jun 30 2015
Juno-Celgene in Immunotherapy Deal, Initial Deal Value $1B - Analyst Blog Jun 30 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK